12:00 AM
 | 
Nov 05, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Arrowhead preclinical data

In a mouse model of HBV infection, a single injection of subcutaneous ARC-520 produced multi-log reductions in circulating viral antigens and HBV DNA and reduced HBV...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >